Brokerages Set LeMaitre Vascular, Inc. (NASDAQ:LMAT) PT at $67.60

LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the six brokerages that are presently covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1 year target […]

Leave a Reply

Your email address will not be published.

Previous post Aptose Biosciences Inc. (NASDAQ:APTO) Receives $37.67 Average Price Target from Brokerages
Next post Brokerages Set Verve Therapeutics, Inc. (NASDAQ:VERV) PT at $30.00